Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications
Min Xing, Chang Zhou, Yi Tang, Shuhui Xu, Shasha Zhou, Weiai Liu et al. Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications. // International Journal of Cancer. – 2026. – DOI: 10.1002/ijc.70704. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ijc.70704?af=R
Min Xing, Chang Zhou, Yi Tang, Shuhui Xu, Shasha Zhou, Weiai Liu, & Huiping Liu (2026). Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications. International Journal of Cancer. https://doi.org/10.1002/ijc.70704
Min Xing, et al. “Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.” International Journal of Cancer, 2026. doi:10.1002/ijc.70704.
@article{Xing2026,
title = {Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications},
author = {Xing, Min and Zhou, Chang and Tang, Yi and Xu, Shuhui and Zhou, Shasha and Liu, Weiai and Liu, Huiping},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70704},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ijc.70704?af=R}
}
Genetic variation is a major cause of male infertility, and defining the underlying mechanisms is essential for developing effective interventions. SSX1 is a primate specific gene whose deficiency has been linked to sperm malformations...
In recent years, the therapeutic potential of dexmedetomidine in septic shock and sepsis-induced acute kidney injury (SAKI) has garnered increasing attention. While independent studies have demonstrated that dexmedetomidine activates...
Single-cell technologies are yet to transform routine oncology practice, partly owing to a scarcity of large, clinically annotated patient cohorts. A study introduces LuCaS+, a multicenter single-nucleus RNA sequencing atlas of lung...